A champion of leadership education at HKS, Gergen leaves a lasting legacy as a political analyst, adviser, and leadership ...

March 2, 2020, Paper: "Corporate purpose is now the focus of a fundamental and heated debate, with rapidly growing support for the proposition that corporations should move from shareholder value ...

2020, Book Chapter: "We review the literature on corporate sustainability and provide directions for future research. Our review focuses on three actions: measuring, managing and communicating ...

November 30, 2023, Video: "The role of immigration in shaping the nation's economy remains a hotly contested area of debate. Factors such as the real economic benefits of high-skilled versus ...

May 2020, Paper, "Impact investing has grown significantly over the past 15 years. From a niche investing segment with only $25 billion AUM in 2013 (WEF 2013), it experienced double-digit growth and ...

June 15, 2021, Video: "Rebecca Henderson teaches at the Harvard Business School, but she’s a vocal critic of “business as usual.” In fact, her scholarly research focuses on how we need to change ...

Former national security advisor and HKS faculty member Jake Sullivan says negotiations following the Iran strikes are key ...

September 2, 2021, Video: "Renowned Harvard Business School professor Dr. John Kotter has studied, written, and lectured about leadership for decades. In his newest book, Change, Kotter dives into how ...

Research from the Shift Project examines the effects of paid sick leave laws.

April 18, 2025, Paper: "We examine whether information in the 10-K Business Description section on f irms’ development and deployment of climate solution products and services can be used to assess ...

February 2020, Book, "Don't fly blind. See how the power of experiments works for you. When it comes to improving customer experiences, trying out new business models, or developing new products, even ...

September/October 2021, Paper: "On November 30, 2020, Moderna Therapeutics announced that Phase III clinical trials for its messenger RNA vaccine demonstrated 95% protective efficacy against the ...